These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1781870

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.
    Aledort LM, Hilgartner MW, Pike MC, Gjerset GF, Koerper MA, Lian EY, Lusher JM, Mosley JW.
    BMJ; 1992 Jan 25; 304(6821):212-6. PubMed ID: 1346752
    [Abstract] [Full Text] [Related]

  • 3. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI, Molina R, Senent ML, Monzó E, Lerma MA, Dasí MA, Monteagudo E, Aznar JA.
    Sangre (Barc); 1992 Jun 25; 37(3):169-74. PubMed ID: 1440093
    [Abstract] [Full Text] [Related]

  • 4. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
    Phillips AN, Sabin CA, Elford J, Bofill M, Janossy G, Lee CA.
    BMJ; 1994 Jul 30; 309(6950):309-13. PubMed ID: 7916226
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group.
    Mannucci PM, Gringeri A, Savidge G, Gatenby P, Laurian Y, Pabinger-Fasching I, Martinez-Vazquez JM, Hessey EW, Steel HM.
    Br J Haematol; 1994 Jan 30; 86(1):174-9. PubMed ID: 7912097
    [Abstract] [Full Text] [Related]

  • 7. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT.
    JAMA; 1994 Aug 10; 272(6):437-42. PubMed ID: 7913730
    [Abstract] [Full Text] [Related]

  • 8. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G, Karafoulidou A, Gialeraki A, Katsarou O, Milona I, Kapsimali V, Mandalaki T, Hatzakis A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep 01; 19(1):89-97. PubMed ID: 9732075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AIDS and hemophilia: experience in the La Paz Hemophilia Center.
    Magallón Martínez M, Ortega F, Pinilla J.
    Haemostasis; 1992 Sep 01; 22(5):281-92. PubMed ID: 1362177
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The progression of HIV disease in a haemophilic cohort followed for 12 years.
    Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C.
    Br J Haematol; 1993 Feb 01; 83(2):330-3. PubMed ID: 8384472
    [Abstract] [Full Text] [Related]

  • 13. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ, Yu LM, Goetghebeur E, Boag F, McLean K, Gazzard B.
    AIDS; 2000 Mar 31; 14(5):561-71. PubMed ID: 10780719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
    Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, González-Lahoz J.
    N Engl J Med; 1993 Jul 29; 329(5):297-303. PubMed ID: 8100611
    [Abstract] [Full Text] [Related]

  • 16. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, Drummond JE, Vaidya K, Mann DL, Eyster ME.
    N Engl J Med; 1989 Oct 26; 321(17):1141-8. PubMed ID: 2477702
    [Abstract] [Full Text] [Related]

  • 17. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE.
    AIDS; 1992 Jul 26; 6(7):671-7. PubMed ID: 1503686
    [Abstract] [Full Text] [Related]

  • 18. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
    Phillips AN, Sabin CA, Elford J, Bofill M, Lee CA, Janossy G.
    AIDS; 1993 Jul 26; 7(7):975-80. PubMed ID: 8102854
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS.
    N Engl J Med; 1990 Apr 05; 322(14):941-9. PubMed ID: 1969115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.